Pharmaceutical Marketing Regulation Information

Updated August 14, 2007

When you purchase the CollabMed product, you are also hiring our research staff. We research state and federal pharmaceutical marketing laws and regulations and regularly report to your team our findings. Below you will find a sample of some of the information we will provide to you.

Enacted Laws: As of January 2007, eight states and District of Columbia (2003), California (2004, 2005, 2006), Florida (2006) Maine (2003, 2005), New Hampshire (2006), South Carolina (2006), Vermont (2002) and West Virginia (2001) and Minnesota (1993) have laws or resolutions affecting pharmaceutical marketing.

Of those eight states, only five specify reporting requirements in regards to "gifts to practitioners". The states and districts requireing at least annual reporting of marketing expenditures are Minnesota, Vermont, Washington D.C., Maine and West Virginia.

During 2007, at least 27 states propose legislation requiring marketing disclosures by drug manufacturers, regulating direct-to-consumer advertising of prescription drugs by pharmaceutical companies or prohibiting prescription information from being sold for commercial purposes.